TY - JOUR
T1 - MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis
AU - Bousquet, Jean
AU - Schunemann, Holger J.
AU - Hellings, Peter W.
AU - Arnavielhe, Sylvie
AU - Bachert, Claus
AU - Bedbrook, Anna
AU - Bergmann, Karl-Christian
AU - Bosnic-Anticevich, Sinthia
AU - Brozek, Jan
AU - Calderon, Moises
AU - Canonica, G. Walter
AU - Casale, Thomas B.
AU - Chavannes, Niels H.
AU - Cox, Linda
AU - Chrystyn, Henry
AU - Cruz, Alvaro A.
AU - Dahl, Ronald
AU - De Carlo, Giuseppe
AU - Demoly, Pascal
AU - Devillier, Phillipe
AU - Dray, Gerard
AU - Fletcher, Monica
AU - Fokkens, Wytske J.
AU - Fonseca, Joao
AU - Gonzalez-Diaz, Sandra N.
AU - Grouse, Lawrence
AU - Keil, Thomas
AU - Kuna, Piotr
AU - Larenas-Linnemann, Desiree
AU - Carlsen, Karin C. Lodrup
AU - Meltzer, Eli O.
AU - Mullol, Jaoquim
AU - Muraro, Antonella
AU - Naclerio, Robert N.
AU - Palkonen, Susanna
AU - Papadopoulos, Nikolaos G.
AU - Passalacqua, Giovanni
AU - Price, David
AU - Ryan, Dermot
AU - Samolinski, Boleslaw
AU - Scadding, Glenis K.
AU - Sheikh, Aziz
AU - Spertini, Francois
AU - Valiulis, Arunas
AU - Valovirta, Erkka
AU - Walker, Samantha
AU - Wickman, Magnus
AU - Yorgancioglu, Arzu
AU - Haahtela, Tari
AU - Working group members
AU - Thijs, Carel
PY - 2016/8
Y1 - 2016/8
N2 - The selection of pharmacotherapy for patients with allergic rhinitis (AR) depends on several factors, including age, prominent symptoms, symptom severity, control of AR, patient preferences, and cost. Allergen exposure and the resulting symptoms vary, and treatment adjustment is required. Clinical decision support systems (CDSSs) might be beneficial for the assessment of disease control. CDSSs should be based on the best evidence and algorithms to aid patients and health care professionals to jointly determine treatment and its step-up or step-down strategy depending on AR control. Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon (MACVIA-LR [fighting chronic diseases for active and healthy ageing]), one of the reference sites of the European Innovation Partnership on Active and Healthy Ageing, has initiated an allergy sentinel network (the MACVIA-ARIA Sentinel Network). A?CDSS is currently being developed to optimize AR control. An algorithm developed by consensus is presented in this article. This algorithm should be confirmed by appropriate trials. The Authors.
AB - The selection of pharmacotherapy for patients with allergic rhinitis (AR) depends on several factors, including age, prominent symptoms, symptom severity, control of AR, patient preferences, and cost. Allergen exposure and the resulting symptoms vary, and treatment adjustment is required. Clinical decision support systems (CDSSs) might be beneficial for the assessment of disease control. CDSSs should be based on the best evidence and algorithms to aid patients and health care professionals to jointly determine treatment and its step-up or step-down strategy depending on AR control. Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon (MACVIA-LR [fighting chronic diseases for active and healthy ageing]), one of the reference sites of the European Innovation Partnership on Active and Healthy Ageing, has initiated an allergy sentinel network (the MACVIA-ARIA Sentinel Network). A?CDSS is currently being developed to optimize AR control. An algorithm developed by consensus is presented in this article. This algorithm should be confirmed by appropriate trials. The Authors.
KW - Allergic rhinitis
KW - conjunctivitis
KW - Allergic Rhinitis and its Impact on Asthma
KW - MACVIA-LR
KW - information and communication technology
KW - clinical decision support system
U2 - 10.1016/j.jaci.2016.03.025
DO - 10.1016/j.jaci.2016.03.025
M3 - Article
C2 - 27260321
SN - 0091-6749
VL - 138
SP - 367-374.e2
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 2
ER -